CIK 0001785530
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Werewolf Therapeutics, Inc.
Sign in to watch- Ticker
- HOWL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 823523180
- Phone
- +1 617-952-0555
- Business address
- 303 WYMAN STREET, SUITE 300, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-27 | EVNIN LUKE Director | Sale 10b5-1 | −46,664 | $1.72 | $80K | 4,263,196 |
| 2025-10-27 | MPM BioVentures 2014, L.P. 10% owner | Sale 10b5-1 | −72,709 | $1.72 | $125K | 6,645,961 |
| 2025-10-27 | GADICKE ANSBERT 10% owner | Sale 10b5-1 | −72,709 | $1.72 | $125K | 6,645,961 |
| 2025-06-12 | Lazarus Alon Director | Grant or award · Stock Option (right to buy) | +27,000 | 27,000 | ||
| 2025-06-12 | Morrison Briggs Director | Grant or award · Stock Option (right to buy) | +27,000 | 27,000 | ||
| 2025-06-12 | Chatterjee Meeta Director | Grant or award · Stock Option (right to buy) | +27,000 | 27,000 | ||
| 2025-06-12 | EVNIN LUKE Director | Grant or award · Stock Option (right to buy) | +27,000 | 27,000 | ||
| 2025-06-12 | Sherman Michael A. Director | Grant or award · Stock Option (right to buy) | +27,000 | 27,000 | ||
| 2025-06-12 | Singhal Anil K. Director | Grant or award · Stock Option (right to buy) | +8,358 | 8,358 | ||
| 2025-06-12 | Atkins Michael B. Director | Grant or award · Stock Option (right to buy) | +27,000 | 27,000 | ||
| 2025-06-11 | Singhal Anil K. Director | Grant or award · Stock Option (right to buy) | +9,000 | 9,000 | ||
| 2025-05-14 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +162,539 | $0.98 | $159K | 6,237,482 |
| 2025-05-13 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +52,974 | $0.98 | $52K | 6,074,943 |
| 2025-05-12 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +320,913 | $0.86 | $276K | 6,021,969 |
| 2025-05-01 | Bloom Steven H. Chief Business Officer | Grant or award · Stock Option (right to buy) | +201,720 | 201,720 | ||
| 2025-03-27 | MPM BioVentures 2014, L.P. 10% owner | Option exercise | +22,758 | $0.09 | $2K | 3,210,756 |
| 2025-03-27 | MPM BioVentures 2014, L.P. 10% owner | Sale | −1,963 | $1.05 | $2K | 3,208,793 |
| 2025-03-27 | MPM BioVentures 2014, L.P. 10% owner | Option exercise · Warrant (Right to Buy) | −4,015 | 0 | ||
| 2025-03-27 | MPM BioVentures 2014, L.P. 10% owner | Option exercise · Warrant (Right to Buy) | −18,743 | 0 | ||
| 2025-03-27 | EVNIN LUKE Director | Option exercise | +28,113 | $0.09 | $3K | 4,312,285 |
Page 9 of 17 · 335 trades